{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-015802","form_type":"8-K","ticker":"NHC","cik":"0001047335","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2026-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:31.863846+00:00","generated_at":"2026-05-14T19:37:21.174701+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"NHC Q1 2026 revenue up 2.2% to $381.8M; adjusted EPS $1.91 vs $1.59","bullets":["GAAP net income $35.9M ($2.27 diluted EPS) vs $32.2M ($2.07) a year ago.","Adjusted net income $30.1M ($1.91 diluted EPS), up 21.1% YoY.","Net operating revenues $381.8M, up 2.2% from $373.7M in Q1 2025.","No guidance or dividend changes announced in the release."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-015802","json":"https://secwatch.observer/filing/0001437749-26-015802.json","markdown":"https://secwatch.observer/filing/0001437749-26-015802.md","text":"https://secwatch.observer/filing/0001437749-26-015802.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1047335/000143774926015802/0001437749-26-015802-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1047335/000143774926015802/nhc20260506c_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T19:37:21.174701+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6a7e2e930df400f1120097dde2dd56ce12b48456","claim":"NATIONAL HEALTHCARE CORP reported the quarter ended March 31, 2026 results: revenue $381,821,000, net income $35,857,000, EPS $2.27.","evidence_excerpt":"National HealthCare Corporation (NYSE American: NHC), the nation's oldest publicly traded senior health care company, announced today net operating revenues for the quarter ended March 31, 2026 totaled $381,821,000 compared to $373,697,000 for the quarter ended March 31, 2025, an increase of 2.2%. For the quarter ended March 31, 2026, the reported GAAP net income attributable to NHC was $35,857,000 compared to $32,205,000 for the same period in 2025. Excluding the unrealized gains in our marketable equity securities portfolio and other non-GAAP adjustments, adjusted net income for the quarter ended March 31, 2026 was $30,089,000 compared to $24,838,000 for the same period in 2025, an increase of 21.1% (*) . The GAAP diluted earnings per share were $2.27 and $2.07 for the quarters ending March 31, 2026 and 2025, respectively.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774926015802/0001437749-26-015802-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2026"},{"label":"Revenue","value":"$381,821,000"},{"label":"Net income","value":"$35,857,000"},{"label":"EPS","value":"$2.27"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}